News

Pharmaceutical Technology21m
FDA approves Abeona’s $3.1m cell therapy for rare skin disease
Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...
Pharmaceutical Technology20m
AstraZeneca’s Truqap fails in another Phase III trial
The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.
Pharmaceutical Technology17m
FDA approves AbbVie’s upadacitinib for giant cell arteritis
The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).